[ad_1]
• Investors now use psilocybin instead of THC
• The first clinical studies are successful
• Champignon Brands occupies niche markets
After the 2017 and 2018 cannabis hype, the IPO of Canadian mushroom group Champignon-Brands could put investors in a new frenzy. Unlike the cannabis boom, it’s no longer about the active ingredients tetrahydrocannabinol (THC) and cannabidiol (CBD), but about the substances psilocybin and psilocin contained in so-called magic mushrooms.
The magic of the magic bullet
Very little researched psilocybin, which occurs especially in special types of mushrooms, is considered by experts to be a beacon of medical and therapeutic hope. The active ingredient is said to be suitable for the treatment of addiction disorders, anxiety, migraines and depression. To fully verify the potential effectiveness of this substance, a large number of research institutions worldwide are now working on the active substance. In 2016, two EE studies. USA They should even prove that psilocybin can relieve anxiety and depression in people with severe cancer.
Consequently, the reputation of the substance that was already investigated in the 1960s and 1970s has changed significantly. While psilocybin has had a reputation for being a dangerous poison, a hippie drug, and a substitute for LSD, the psychedelic substance is now considered a possible miracle cure.
Star Investors Trust Magic Mushrooms
Heady mushrooms have long impressed PayPal founder Peter Thiel, who also made a name for himself as an investor thanks to early investments in Facebook and Airbnb. For example, a Thiel-funded startup is investigating the effects of psilocybin in subjects suffering from severe depression.
Frankfurt-born Peter Thiel is not only interested in the miracle cure for magic mushrooms, but also well-known Canadian businessman and star of shark tank Kevin O’Leary. So O’Leary invested some time ago in the Canadian-based MindMed mushroom company.
From mushroom tea to pharmaceuticals.
Currently, however, not only star investors await the mushroom’s breakthrough, but also Champignon Brands’ managing directors and shareholders. The Vancouver-based company, which was founded in 2019, specializes in the cultivation, distribution and distribution of various mushroom products. Canadians currently sell various types of tea enriched with the active ingredients of various medicinal mushrooms. According to the group, these teas should not only boost mental performance, but also detoxify, reduce stress, and strengthen the immune system. In addition, the group, together with the Canadian company Drip Coffee, offers several coffee specialties to which selected mushroom extracts have been added.
However, in the long term, the group would like to focus on the cultivation of psychoactive mushrooms and the extraction of psilocybin, which should then be made available for clinical use.
The sector is still in its infancy.
With the Canadian companies Champignon-Brands and MindMed, the magic mushroom industry is just beginning. Consequently, the two corporations, which have only been trading on the stock exchange for a few weeks, only have a market capitalization of around C $ 35-150 million.
A pioneer in the industry.
Unless other mushroom companies like mushrooms sprout from the ground in the coming weeks and months and increase competition, it is very possible that Champignon-Brands is making optimal use of its first player lead and is becoming a pioneer in the industry. Duration established in the market niche of medicinal mushrooms.
Lessons from the cannabis boom
Many speculative investors may well remember the hype surrounding the Canopy Growth, Tilray and Aurora Cannabis stocks and know full well that it was the investors who got on the “hemp train” at the end of the hype, now sometimes they have They complain about book losses of more than 90 percent. For example, Tilray’s shares rose from less than $ 20 to as high as $ 300 in just a few days, generating an impressive recovery of more than 1,000 percent on the floor. Stock certificates are now trading at around $ 7. Consequently, even investors who started with around $ 50 are now looking for book losses of more than 80 percent.
Pierre Bonnet / finanzen.net
More News on Champignon Brands Inc Registered Shs Reg S
Image sources: anitram / Shutterstock.com
